BATCH OF 10 TEOSYAL REDENSITY [II] PURESENSE (2x1ml) TEOXANE

TEOSYAL REDENSITY [II] PURESENSE (2x1ml) TEOXANE

USE MEDICAL STRICT. Medical device. Injection of hyaluronic acid. Use reserved for dermatologists and aesthetic doctors because they require a medical procedure.

DESCRIPTION

A DIFFERENT GEL TO TREAT EYE CIRCLES FOR A NATURAL AND LONG LASTING CORRECTION. TEOSYAL REDENSITY [II] PURESENSE is a major innovation in the treatment of under-eye circles with a subtle mix of non cross-linked and cross-linked hyaluronic acid. Its rheological profile is particularly adapted to the fragile and challenging under-eye circles area. TEOSYAL REDENSITY is designed for under-eye correction and tear trough treatment.  In addition, its low hydroscopic behaviour and ideal viscoelasticity guarantee natural results and reduce the risk of swelling.

PRESENTATION

• TEOSYAL REDENSITY [II] PURESENSE is a viscoelastic gel of hyaluronic acid in cross-linked and non-crosslinked form, and of non-animal origin.
• This gel is sterile, non-pyrogenic, transparent, and contains 0.3% by weight of lidocaine hydrochloride, for its anesthetic properties.
• Each box contains two pre-filled syringes of TEOSYAL REDENSITY [II] PURESENSE.  
• For each syringe, the box contains two 30G1 / 2 "sterile needles and two traceability labels (one to be given to the patient, and a label to be kept by the doctor in the patient's chart). The volume of each syringe is indicated on the carton and on each syringe.

INJECTION DEPTH

Supra-periosteal, deep sub-orbicular.

BLISTER PACK

2 x 1 ml.

NEEDLE

30G1/2”.

INDICATION

• TEOSYAL REDENSITY [II] PURESENSE is specially indicated for hollow eye-circles and tear trough.
• AN IDEAL VISCOELASTICITY: HIGH SPREADING CAPABILITY.
• It cannot be used to treat sunken under-eye circles and malar bags.
• A DIFFERENT GEL DESIGNED TO TREAT EYE CIRCLES WITH A NATURAL AND LONG LASTING CORRECTION.

NJECTION AREAS

• Palpebral line.
• Tear trough.
• Palpebromalar groove.
• Mediojugal fold.
• Nasolabial folds.
• Correction of the under-eye circles. 
• Minimal palpebral or malar bags.

COMPOSITION

A SOPHISTICATED AND SYNERGISTIC 3-IN-1 FORMULA. Mix of non cross-linked and cross-linked hyaluronic acid 15 mg/ml + lidocain 0,3%:

• SEMI-CROSSLINKED HYALURONIC ACID (HA) 15 mg/g. CROSS KINKING DEGREE 1/6.
• Acide hyaluronique: 15 mg/g (mélange de AH réticulé et non-réticulé).
• Chlorhydrate de lidocaïne 3 mg : 0,3%.
• Tampon phosphate supplémenté pH 7,3 qsp 1 ml.
• DERMO-RESTRUCTURING COMPLEX. 8 amino acids: Glycine, Lysine, Threonine, Proline, Isoleucine, Leucine, Valine, Arginine 3 antioxydants: Glutathion, N-Acetyl-L-cysteine, Alphalipoic acid. 2 minerals: Zinc and Copper. 1 vitamin: B6.

DURATION 

9 – 12 months.

RESULTS

The results can usually be seen immediately. The hyaluronic acid diffuses through your skin. On the surface, it increases the skin’s hydration, softness and suppleness.

GAMME TEOSYAL BY TEOXANE

The TEOXANE laboratories guarantee gels of hyaluronic acid of extreme purity goes well beyond the standards required by législation.pour optimum safety.

ENHANCERS

• REDENSITY I PureSense Redensity [I] - AH non cross-linked 15 mg/g - 3 x1 ml ou 2 x1 ml - Dermal deep rehydration and redensification.
• MESO - AH non cross-linked - 15 mg/ml - 2 x 1 ml - Dermis redensification - Mesotherapy - Skin revitalization and rehydration.

ESSENTIALS

• FIRST LINE 20 mg/g - AH cross-linked 1/5 - 2 x 0,7 ml - Superficial line correction.
• TOUCH UP 25 mg/g - AH cross-linked 3/5 - 2 x 0,5 ml - The final touch.
• GLOBAL 25 mg/g - AH cross-linked 3/5 - 2 x 1 ml - Medium line correction.
• DEEP 25 mg/g - AH cross-linked 3/5 - 2 x 1 ml - In-depth filling.

VOLUMIZERS

• ULTRA DEEP 25 mg/g - AH cross-linked 4/5 - 2 x 1,2 ml - Volume creation for targeted areas.
• ULTIMATE 22 mg/g - AH cross-linked 5/5 - 2 x 1 ml - Volume recovery for wide areas.

SPECIFICS

• REDENSITY II PureSense Redensity [II] - AH Semi-cross-linked 15 mg/g - 2 x 1 ml - Correction adapted to under-eye circles.
• KISS 25 mg/g - AH cross-linked 4/5 - 2 x 1 ml - Lip enhancement.